Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

NCT01518374 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.

NCT NCT01518374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01518374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
Lead sponsor
Avid Radiopharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
May 3, 2017
Enrollment
1,768 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment, neurodegenerative diseases